Joint Launch Event of Projects from the Call ‘New Testing and Screening Methods to Identify Endocrine Disrupting Chemicals’
The current testing tools, including regulatory in vivo tests and novel in vitro assays, do not appropriately identify effects related to certain less studied endocrine-mediated pathways or health outcomes, in which endocrine disruptors may be implicated. The focus of proposals should be on the most urgent regulatory needs, e.g., methods addressing the thyroid axis, developmental neurotoxicity, metabolic disorders, female reproduction and non-genotoxic carcinogenicity. Proposals should involve, in addition to academic researchers, regulatory agencies and other actors as appropriate.
Horizon 2020 – Societal Challenges
31 January, 2019,